Clinical Trials Must Prioritize Corroboration Over Mere Replication for Robust Scientific Knowledge

A new argument in the New England Journal of Medicine challenges the traditional focus on reproducibility in biomedical research, asserting that corroboration—the convergence of independent evidence from methodologically distinct studies—is essential for building durable scientific knowledge. This shift in intellectual framework could prevent significant waste in preclinical research and improve the reliability of clinical development programs.